Contact Us

mHealth rapid tests: Expedite your clinical trial and market strategies

Rapid data. Rapid decisions.

Streamline patient-response monitoring during decentralised clinical trials (DCT), enhance a therapy’s patient-centricity and accelerate differentiation strategies with mHealth near-patient rapid tests.

Using this intuitive companion diagnostic technology provides a future-proof solution for your personalised medicine strategy.

  • Home testing and point-of-care approach
  • Straightforward detection of drug activity markers
  • Multi-location capture and sharing of lab-quality data
  • Faster decision making
  • Simple and secure data management
  • Intuitive monitoring and reporting
  • Patient empowerment via interactive features

Improve your decentralised clinical trial process then make your therapy standout in the crowd

A de-risked approach

Working with Abingdon Health is a de-risked approach to adopting mHealth near-patient rapid tests as part of your biosmilar or therapeutic growth strategy.

  • End-to-end rapid test development and manufacture
  • Experience of working with multiple markers and samples
  • Pharmaceutical Industry experience
  • Data management and technical support
  • In-house regulatory and mHealth expertise
  • Ability to adopt legal manufacture status
  • Commercialisation support

Learn more

Contact us to learn more about mHealth near-patient rapid tests.

Pharmaceutical Industry Brochure

Intuitive and cost-effective rapid test technology supporting trial decentralisation and drug product differentiation strategies.